Cart
sales@molnova.com
AMRI-59
CAS No. 923515-92-8
AMRI-59( AMRI 59 | AMRI59 )
Catalog No. M27848 CAS No. 923515-92-8
AMRI-59 is a potent inhibitor of PrxI with anti-tumor activity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 275 | In Stock |
|
| 5MG | 249 | In Stock |
|
| 10MG | 368 | In Stock |
|
| 25MG | 562 | In Stock |
|
| 50MG | 770 | In Stock |
|
| 100MG | 1032 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 2074 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAMRI-59
-
NoteResearch use only, not for human use.
-
Brief DescriptionAMRI-59 is a potent inhibitor of PrxI with anti-tumor activity.
-
DescriptionAMRI-59 is a potent inhibitor of PrxI with anti-tumor activity.
-
In Vitro——
-
In Vivo——
-
SynonymsAMRI 59 | AMRI59
-
PathwayOthers
-
TargetOther Targets
-
RecptorLPA1
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number923515-92-8
-
Formula Weight401.51
-
Molecular FormulaC25H27N3O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCC(=O)c1cccc(NC(=O)N2CCC(Cc3ccc(cc3)-n3cccc3)CC2)c1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Jonathan Ellery, et al. Identification of compounds acting as negative allosteric modulators of the LPA 1 receptor. Eur J Pharmacol. 2018 Aug 15;833:8-15.
molnova catalog
related products
-
P61 (343 - 355), M. ...
P61 (343 - 355), M. leprae
-
NNMTi
NNMTi? is a substrate site-targeting, selective nicotinamide N-methyltransferase (NNMT) inhibitor (IC50 = 1.2 μM;?50 μM SAM, 100 μM NCA) that reduces 3T3-L1 lipogenesis (EC50 = 30μM) and adipocytes 1-methylnicotinamide level (EC50 = 2.3 μM) without affecting related methyltransferases & enzymes in the NAD+ salvage pathwayNNMTi treatment will rescue age-related deficits in muSC activity to promote superior regeneration post-injury in aging muscle.
-
Linalyl Acetate
Linalyl Acetate is a natural product.
